Antiarrhythmic drugs for out-of-hospital cardiac arrest with refractory ventricular fibrillation.
This article is one of ten reviews selected from the Annual Update in Intensive Care and Emergency medicine 2017. Other selected articles can be found online at http://ccforum.com/series/annualupdate2017 . Further information about the Annual Update in Intensive Care and Emergency Medicine is available from http://www.springer.com/series/8901 .
Department of Emergency and Critical Care Medicine, Nippon Medical School, Tama Nagayama Hospital, 2068512, Tama-shi, Tokyo, Japan. t-tagami@nms.ac.jp.|Department of Clinical Epidemiology and Health Economics, The University of Tokyo, School of Public Health, Graduate School of Medicine, 1138555, Bunkyo-ku, Tokyo, Japan. t-tagami@nms.ac.jp.
Takashi
T
Tagami
Department of Clinical Epidemiology and Health Economics, The University of Tokyo, School of Public Health, Graduate School of Medicine, 1138555, Bunkyo-ku, Tokyo, Japan.
Hideo
H
Yasunaga
Department of Emergency and Critical Care Medicine, Nippon Medical School, 1138603, Bunkyo-ku, Tokyo, Japan.
Hiroyuki
H
Yokota
D000638:Amiodarone / Q000494:pharmacology / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology* / Q000627:therapeutic use; D004632:Emergency Medical Services / Q000379:methods; D006801:Humans; D007362:Intensive Care Units / Q000458:organization & administration; D008012:Lidocaine / Q000494:pharmacology / Q000627:therapeutic use; D058687:Out-of-Hospital Cardiac Arrest / Q000188:drug therapy*; D010919:Placebos / Q000494:pharmacology / Q000627:therapeutic use; D011744:Pyrimidinones / Q000494:pharmacology / Q000627:therapeutic use; D014693:Ventricular Fibrillation / Q000188:drug therapy*
D000889:Anti-Arrhythmia Agents; D010919:Placebos; D011744:Pyrimidinones; C076259:nifekalant; D008012:Lidocaine; D000638:Amiodarone